Eisai's New Drug Application for Insomnia Disorder Treatment Lemborexant Submitted in the United States - BioSpace https://t.co/zTUpE8Bi6F — IDRO (@IDROOhio) January 17, 2019
Eisai's New Drug Application for Insomnia Disorder Treatment Lemborexant Submitted in the United States - BioSpace https://t.co/zTUpE8Bi6F
No comments:
Post a Comment